Nyrada Inc. logo
NYR

Nyrada

Pharmaceuticals, Biotechnology & Life Sciences

Drug research and development

Short position

short percentage0.00%
reported shorts16
shares on issue258.682M

Nyrada (ASX:NYR) has 0.00% of its shares on issue reported as short positions as of 5 Oct 2026, or about 16 shares. Over the past 30 days that figure has been broadly flat, and over 90 days it has been broadly flat. Its highest recorded short interest was 0.06% in September 2026. NYR is classified in the Pharmaceuticals, Biotechnology & Life Sciences industry. All figures come from official ASIC short position reports, published with a four trading-day (T+4) delay.

Price & short interest

Toggle series, zoom, and compare · ASIC daily, T+4

NYR community

Sign in to post
Loading community activity...

Research Threads

Bull, bear, catalyst, and news-reaction posts tied directly to NYR.

No threads yet

Start the first NYR research thread

Anchor the conversation with a thesis, a catalyst, or a question worth debating.